Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2013 3
2016 3
2017 2
2018 1
2019 1
2020 5
2021 4
2022 5
2023 7
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis.
Yu C, Zhang F, Ding Y, Li Y, Zhao Y, Gu J, Guo S, Pan W, Jin H, Sun Q, Kang X, Yang Q, Jiang X, Song Z, Lu Q, Pang X, Kuang Y, Deng D, Li Y, Zhang C, Tao J, Xie L, Wang Y, Wang J, Wang G. Yu C, et al. Among authors: guo s. Int Immunopharmacol. 2022 Nov;112:109248. doi: 10.1016/j.intimp.2022.109248. Epub 2022 Sep 18. Int Immunopharmacol. 2022. PMID: 36126411 Clinical Trial.
Epidemiology of urticaria in China: a population-based study.
Li J, Mao D, Liu S, Liu P, Tian J, Xue C, Liu X, Qi R, Bai B, Nie J, Ye S, Wang Y, Li Y, Sun Q, Tao J, Guo S, Fang H, Wang J, Mu Q, Liu Q, Ding Y, Zhang J. Li J, et al. Among authors: guo s. Chin Med J (Engl). 2022 Jun 5;135(11):1369-1375. doi: 10.1097/CM9.0000000000002172. Chin Med J (Engl). 2022. PMID: 35830258 Free PMC article.
Tildrakizumab for moderate-to-severe plaque psoriasis in Chinese patients: A 12-week randomized placebo-controlled phase III trial with long-term extension.
Yu C, Geng S, Yang B, Deng Y, Li F, Kang X, Bi M, Zhang F, Zhao Y, Pan W, Tian Z, Xu J, Zhang Z, Yu N, Duan X, Guo S, Sun Q, Li W, Tao J, Liu Z, Yin Y, Wang G. Yu C, et al. Among authors: guo s. Chin Med J (Engl). 2024 Jan 9. doi: 10.1097/CM9.0000000000002873. Online ahead of print. Chin Med J (Engl). 2024. PMID: 38192233
36 results